Today as I was reading a jouranl's latest edition, i was shocked or terrified rather, the article described how Merck had presented data favorable for its products such as vioxx and fosamax , in the journal named “The Australasian Journal of Bone and Joint Medicine, which is published by Exerpta Medica, a division of Elsevier, the irony is that this journal is not at all indexed in Medline and some articles related to MSDA drugs in each issue presented positive conclusion.
The claim that Merck has created a journal which will serve as a marketing tool was first reported by The Australian sometime back.
Now the question which comes in my mind is that this marketing strategy might help pharmaceuticals to gain the confidence of the medical practitioners who fail to identify the disadvantages related to the drugs after been influenced by what they read in the journals and later they might prescribe the drugs to their patients.
It's high time that common man should be aware of what purpose they are taking the medication and what their sideeffects are?
More about this in coming series :)
No comments:
Post a Comment